delta Opioid receptor subtypes activate inositol-signaling pathways in the production of antinociception - PubMed (original) (raw)

Affiliations

PMID: 9580632

delta Opioid receptor subtypes activate inositol-signaling pathways in the production of antinociception

P Sánchez-Blázquez et al. J Pharmacol Exp Ther. 1998 May.

Abstract

To analyze the selectivity of delta receptor subtypes to regulate different classes of G proteins, the expression of the alpha-subunits of Gi2, Gi3, Go1, Go2, Gq and G11 transducer proteins was reduced by administration of oligodeoxynucleotides (ODNs) complementary to sequences in their respective mRNAs. Mice receiving antisense ODNs to Gi2 alpha, Gi3 alpha, Go2 alpha and G11 alpha subunits showed an impaired antinociceptive response to all the delta agonists evaluated. An ODN to Go1 alpha specifically blocked the antinociceptive effect of the agonist of delta-1 receptors, [D-Pen2,5]enkephalin (DPDPE), without altering the activity of [D-Ala2]deltorphin II or [D-Ser2]-Leu-enkephalin-Thr (DSLET). In mice treated with an ODN to Gq alpha, the effects of the agonists of delta-2-opioid receptors were reduced, but not those of DPDPE. Thus, Go1 proteins are selectively linked to delta-1-mediated analgesia, and Gq proteins are related to delta-2-evoked antinociception. After impairing the synthesis of Go1 alpha subunits, DPDPE exhibited an antagonistic activity on the antinociception produced by [D-Ala2]deltorphin II. After treatment with ODNs complementary to sequences in Gq alpha or PLC-beta 1 mRNAs, the analgesic capacity of [D-Ala2]deltorphin II was diminished. However, the delta-2-agonist did not alter the antinociceptive activity of DPDPE. An ODN complementary to nucleotides 7 to 26 of the murine delta receptor reduced the analgesic potency of [D-Ala2]deltorphin II, but not that observed for DPDPE. In these mice, [D-Ala2]deltorphin II did not antagonize the effect of DPDPE. These results suggest the existence of different molecular forms of the delta opioid receptor, and the involvement of inositol-signaling pathways in the supraspinal antinociceptive effects of delta agonists.

PubMed Disclaimer

Cited by

Role of signalling molecules in behaviours mediated by the δ opioid receptor agonist SNC80.
Dripps IJ, Boyer BT, Neubig RR, Rice KC, Traynor JR, Jutkiewicz EM. Dripps IJ, et al. Br J Pharmacol. 2018 Mar;175(6):891-901. doi: 10.1111/bph.14131. Epub 2018 Feb 9. Br J Pharmacol. 2018. PMID: 29278419 Free PMC article.
Reciprocal modulation of phospholipase Cbeta isoforms: adaptation to chronic morphine.
Chakrabarti S, Liu NJ, Gintzler AR. Chakrabarti S, et al. Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13686-91. doi: 10.1073/pnas.2335885100. Epub 2003 Nov 3. Proc Natl Acad Sci U S A. 2003. PMID: 14597703 Free PMC article.
Differential prevention of morphine amnesia by antisense oligodeoxynucleotides directed against various Gi-protein alpha subunits.
Galeotti N, Ghelardini C, Bartolini A. Galeotti N, et al. Br J Pharmacol. 2001 May;133(2):267-74. doi: 10.1038/sj.bjp.0704081. Br J Pharmacol. 2001. PMID: 11350863 Free PMC article.
Gz mediates the long-lasting desensitization of brain CB1 receptors and is essential for cross-tolerance with morphine.
Garzón J, de la Torre-Madrid E, Rodríguez-Muñoz M, Vicente-Sánchez A, Sánchez-Blázquez P. Garzón J, et al. Mol Pain. 2009 Mar 10;5:11. doi: 10.1186/1744-8069-5-11. Mol Pain. 2009. PMID: 19284549 Free PMC article.
Protein kinase Cε is required for spinal analgesic synergy between delta opioid and alpha-2A adrenergic receptor agonist pairs.
Schuster DJ, Kitto KF, Overland AC, Messing RO, Stone LS, Fairbanks CA, Wilcox GL. Schuster DJ, et al. J Neurosci. 2013 Aug 14;33(33):13538-46. doi: 10.1523/JNEUROSCI.4013-12.2013. J Neurosci. 2013. PMID: 23946412 Free PMC article.

delta Opioid receptor subtypes activate inositol-signaling pathways in the production of antinociception - PubMed (original) (raw)